, Tracking Stock Market Picks
Enter Symbol:
Repros Therapeutics Inc. (RPRX) [hlAlert]

down 30.96 %

Repros Therapeutics Inc. (RPRX) upgraded to Buy with price target $12 by Ladenburg Thalmann

Posted on: Tuesday,  Mar 17, 2009  11:25 AM ET by Ladenburg Thalmann

Ladenburg Thalmann rated Buy Repros Therapeutics Inc. (NASDAQ: RPRX) on 03/17/2009, when the stock price was $7.17. Since then, Repros Therapeutics
Inc. has lost 30.96% of its value until Ladenburg Thalmann rated RPRX Neutral on 07/01/2009, when the price was $4.95.
If you would have followed this Ladenburg Thalmann's recommendation on RPRX, you would have lost 30.96% of your investment in 106 days.

Repros Therapeutics Inc. (RPRX) is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs. The Company's principal drug, Proellex, is a selective blocker of the progesterone receptor and is being developed for the treatment of uterine fibroids, anemia associated with excessive menstrual bleeding relating to uterine fibroids, or anemia associated with uterine fibroids and endometriosis. The second product candidate, Androxal, is a single isomer of clomiphene citrate and an orally active small molecule compound.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/28/2013 3:25 PM Buy
16.05 25.00
as of 12/31/2009
1 Week   
1 Month   
3 Months   
1 YTD down  -52.94 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2012 8:25 AM Buy
16.16 18.00
3/16/2011 9:25 AM Buy
5.46 9.00
8/20/2010 9:25 AM Buy
0.41 1.50
7/1/2009 4:25 PM Hold
4.95 5.25
3/17/2009 11:25 AM Buy
7.17 12.00
9/30/2008 9:25 AM Buy
6.59 16.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy